Results 71 to 80 of about 11,492 (193)

The relationship between follicle-stimulating hormone and metabolic dysfunction-associated fatty liver disease in men

Nutrition & Diabetes
Objectives The present study aimed to investigate the relationship between male hormones and metabolic dysfunction-associated fatty liver disease (MAFLD) in males.
Dong-Hua Bin, Fang Liu, Ke-Ping Peng, Min Zhan, Yan Tan, Qiao Liu, Wang Tang, Zeng-Nan Mo, Xiong-Jun Peng, Gui-Xiang Tian   +9 more
doaj   +1 more source

Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction

Aging Cell, Volume 25, Issue 10, October 2026.
Hepatocyte‐specific GHR ablation is associated with hepatic and age‐related pathologies, triggering adipose‐liver crosstalk via elevated circulating GH and subsequent CD36‐dependent hepatic steatosis. This loss impairs STAT5b phosphorylation and enhances PPARγ nuclear activation, upregulating Pdk4 and Cd36 to drive mitochondrial dysfunction and ectopic
Kangkang Yang, Yuli Jian, Fusheng Pang, Ming Ying, Qian Yang, Nian Liu, Shujing Wang, Yingjie Wu   +7 more
wiley   +1 more source

MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development

With around one billion of the world’s population affected, the era of the metabolic-associated fatty liver disease (MAFLD) pandemic has entered the global stage.
Ana Petrovic, Kristina Bojanic, Omar Khaznadar, Martina Smolic, Fabian Gjoni, Stefan Gjoni, Justinija Steiner, Marija Hefer, Farah Khaznadar   +8 more
core   +1 more source

Outcome of Patients with Metabolic-Associated Fatty Liver Disease Who Are Infected with SARS-CoV-2: A Meta-Analysis

Acta Medica Indonesiana
Background: Metabolic-associated fatty liver disease (MAFLD) is excess fat accumulation in the liver due to metabolic syndrome. Coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Chyntia Olivia Maurine Jasirwan, Dyah Purnamasari, Alvina Widhani, Tasya Kamila   +3 more
doaj  

TyG-BMI as a superior predictor of MAFLD and pre-MAFLD in Chinese adults: a cross-sectional study

BMC Gastroenterology
Background Metabolic-associated fatty liver disease (MAFLD), a highly prevalent global liver disorder, requires early diagnosis and treatment to delay progression, yet lacks simple diagnostic tools.
Xinru Huang, Yanyun Hu, Lining Dong, Liying Zhu, Jie Li, Ji Hu, Wei Shao, Yongde Peng, Fang Liu   +8 more
doaj   +1 more source

Impact of bariatric surgery on alcohol‐use disorder and alcohol‐related liver disease: A retrospective study

Addiction, Volume 121, Issue 10, Page 2682-2690, October 2026.
Abstract Background and aims Increased risk of alcohol dependence is recognised following bariatric surgery. Modified gastrointestinal anatomy and neurohormonal profiles lead to altered alcohol metabolism, peak blood alcohol concentrations and enhanced reward circuits and cravings.
Thomas J. Williams, Andrew J. Palmer, Jason P. Connor, Gerald Holtmann, Paul J. Clark   +4 more
wiley   +1 more source

Metabolic-associated fatty liver disease (MAFLD) in coeliac disease

, 2021
Background and aims: Coeliac disease (CD) is considered a high-risk condition for developing non-alcoholic fatty liver disease (NAFLD) and other related metabolic disorders, particularly after commencing gluten-free diet (GFD). Recently, a new concept of
Tortora R., Alisi A., Fiorentino A., Morisco F., Testa A., Rispo A., Cossiga V., Guarino M., Imperatore N., Ricciolino S.   +9 more
core   +1 more source

Discovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLD

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
Proteomic discovery and validation of EGFL7 as a potential non‐invasive biomarker in MASLD. EGFL7 was identified as the top‐ranked proteomic feature in a clinical cohort, demonstrated diagnostic performance comparable to FIB‐4 for fibrosis assessment, and was associated with increased all‐cause mortality risk in the UK Biobank.
Heather Collis, Sara F. Hansson, Patrik Nasr, Cecilia Jönsson, Mathias Liljeblad, Björn Carlsson, Showgy Ma'ayeh, Boxi Zhang, Jana de Wiljes, Mattias Ekstedt, Stergios Kechagias, Jane Knöchel   +11 more
wiley   +1 more source

Relationship between phthalates and MAFLD.

As a new definition for the evidence of hepatic steatosis and metabolic dysfunctions, the relationship between phthalates (PAEs) and metabolic dysfunction-associated fatty liver disease (MAFLD) remains virtually unexplored.
Yue Zhang (30585), Wenzhi Xiang (18414689), Junhao Sun (9159150), Siqi Yang (1678081), Xiubo Jiang (395125)   +4 more
core   +1 more source

Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study

, 2021
Colorectal adenoma is linked to metabolic dysfunction. Metabolic dysfunction-associated fatty liver disease (MAFLD) has a precise definition and three subtypes, including non-obese MAFLD.
Tsutomu Nagata, Shuhei Fukunaga, Dan Nakano, Keiichi Mitsuyama, Akihiro Ouchi, Takuji Torimura, Mohammed Eslam, Hirohiko Abe, Takumi Kawaguchi, Hidemichi Kawata, Ryuichi Nouno, Hidefumi Kuroki, Jacob George, Koutaro Kawaguchi   +13 more
core   +1 more source